Upto 95.7% Accuracy - AI's Influence on Genetic Disease Prediction -written by Poonam Chanchlani (BCA, Data Science)

In a  scholarly article titled "Evaluation of artificial intelligence techniques in disease diagnosis and prediction" by Nafiseh Ghaffar Nia, Erkan Kaplanoglu, and Ahad Nasab, the potential of AI techniques in revolutionizing disease diagnosis and prediction is explored . Here, we delve into the key insights from this research and examine the challenges, solutions, and future prospects in the field of AI-driven healthcare.
 

Enhancing Genetic Disorder Prediction:

AI, particularly Machine Learning (ML) and Deep Learning (DL) methods, has emerged as a powerful tool for predicting and categorizing genetic disorders. The diverse genotypes of these disorders have posed challenges for scientists in identifying biomarkers. AI, however, holds the promise of significantly improving accuracy. For instance, an Artificial Neural Network (ANN)-based model achieved impressive accuracy rates of 85.7%, 84.9%, and 84.3% during training, testing, and validation phases, respectively. In psychiatry, AI demonstrated accuracy ranging from 48% to 95%. Despite the need for automated predictors for genetic diseases, limitations persist in data sample size and the availability of high-standard models.

 

Revolutionizing Dermatology Diagnosis:

AI's potential in dermatology is vast but underutilized. Machine Learning (ML) and Deep Learning (DL) models can learn from data to diagnose and classify various skin diseases. This technology is particularly crucial for early detection, which is essential for effective skin cancer treatment. AI-based algorithms, especially Convolutional Neural Networks (CNNs), can analyze skin images, providing accurate diagnoses. They prove especially valuable when young specialists may lack the experience to detect skin diseases accurately. AI not only saves lives but also reduces healthcare costs. For instance, DL outperformed ensemble learning in skin cancer lesion analysis, achieving accuracy rates of 91.85% for prediction and 90.1% for classification. The synergy of Bayesian DL and active learning also proved highly effective in diagnosing skin cancer.
 

Optimizing Prostate Cancer Diagnosis and Treatment:

The convergence of digital pathology and AI has led to more precise diagnoses of prostate cancer. AI aids in predicting patient responses to different therapy methods, enhancing the effectiveness of treatment. AI-based technologies have demonstrated impressive accuracy in diagnosing prostate lesions, predicting patient survival rates, and determining treatment responses. MRI images labeled with histopathology information achieved an 89% accuracy rate in prostate cancer diagnosis. Moreover, a novel DL approach called XmasNet excelled in classifying prostate cancer lesions using 3D multiparametric MRI data. AI's role in prostate cancer diagnosis continues to evolve, with the potential to further enhance patient care.
 

Early Detection of Lung Cancer:

Early detection of lung cancer significantly improves survival rates, and AI has proven instrumental in this regard. AI-driven Computer-Assisted Diagnosis (CAD) based on deep learning frameworks achieved high accuracy in classifying different types of lung cancer. Deep Convolutional Neural Networks (CNNs) demonstrated effectiveness in distinguishing adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. CNNs, when compared to other deep neural networks, outperformed with an 84% accuracy rate. Furthermore, AI algorithms can analyze CT and X-ray images to identify early-stage lung cancer, contributing to improved patient outcomes.
 

Revolutionizing Respiratory Infection Detection:

AI algorithms play a vital role in the early detection and analysis of respiratory infections. A deep learning-based Convolutional Neural Network (CNN) achieved 93% accuracy in analyzing respiratory audio data for detecting Chronic Obstructive Pulmonary Disease. Another CNN-based model achieved a 95.7% accuracy rate in diagnosing Covid-19 using X-ray images.

 

Challenges and Future Directions:

While AI holds immense promise in disease diagnosis and prediction, several challenges exist. These include the need for large datasets for training, data labeling complexities, computational complexity in DL models, and model generalization beyond predefined boundaries. Addressing these challenges requires innovations like data augmentation, model compression techniques, and more effort from the medical community to promote AI adoption. Privacy concerns also necessitate global coordination in the use of AI in healthcare.

 

In the future, ML and DL algorithms are expected to continue improving disease prediction and diagnosis, leading to more personalized treatment plans. However, ensuring diverse and unbiased data for training remains crucial to prevent inaccuracies and discrimination. The integration of AI in healthcare procedures is a promising avenue for enhancing patient care.

 

Conclusion

AI techniques, particularly ML and DL, are poised to reshape disease diagnosis and prediction. Their potential to enhance accuracy and efficiency in healthcare is remarkable, with applications ranging from genetic disorder prediction to dermatology, prostate cancer diagnosis, lung cancer detection, and respiratory infection analysis. Challenges remain, but ongoing research and innovation hold the key to unlocking the full potential of AI in healthcare, ultimately improving patient outcomes and well-being.